Literature DB >> 28382688

Epimedii Herba: A Promising Herbal Medicine for Neuroplasticity.

Jae-Heung Cho1, Jae-Young Jung1, Beom-Joon Lee1, Kyungjin Lee1, Jae-Woo Park1, Youngmin Bu1.   

Abstract

Epimedii Herba (EH) is an herbal medicine originating from several plants of the genus Epimedium. It is a major therapeutic option for kidney yang deficiency syndrome, which is closely related to androgen hormones and also has been used to treat hemiplegia following a stroke in traditional medicine of Korea and PR China. To date, many clinical and basic researches of EH have shown the activities on functional recovery from brain diseases. Recently, neuroplasticity, which is the spontaneous reaction of the brain in response to diseases, has been shown to accelerate functional recovery. In addition, androgen hormones including testosterone are known to be the representative of neuroplasticity factors in the brain recovery processes. In this review, we described the neuro-pharmacological activities of EH, focusing on neuroplasticity. Thirty-three kinds of papers from MEDLINE/PubMed, EMBASE, and CNKI were identified and analyzed. We categorized the results into five types based on neuroplasticity mechanisms and presented the definition of each category and briefly described the results of these papers. Altogether, we can suggest that neuroplasticity is a novel viewpoint for guiding future brain research of EH and provide the evidence for the development of new clinical applications using EH in the treatment of brain diseases.
Copyright © 2017 John Wiley & Sons, Ltd. Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Alzheimer; Epimedium Herba; brain disease; dementia; functional recovery; neuroplasticity; synaptic plasticity; testosterone; traditional medicine Asia and Oceania

Mesh:

Substances:

Year:  2017        PMID: 28382688     DOI: 10.1002/ptr.5807

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  6 in total

1.  Mining Therapeutic Efficacy from Treasure Chest of Biodiversity and Chemodiversity: Pharmacophylogeny of Ranunculales Medicinal Plants.

Authors:  Da-Cheng Hao; Li-Jia Xu; Yu-Wei Zheng; Huai-Yu Lyu; Pei-Gen Xiao
Journal:  Chin J Integr Med       Date:  2022-07-09       Impact factor: 2.626

2.  Metabolic engineering Escherichia coli for efficient production of icariside D2.

Authors:  Xue Liu; Lingling Li; Jincong Liu; Jianjun Qiao; Guang-Rong Zhao
Journal:  Biotechnol Biofuels       Date:  2019-11-06       Impact factor: 6.040

Review 3.  Chinese herbs and acupuncture to improve cognitive function in Alzheimer's disease.

Authors:  Wei WuLi; Horng-Jyh Harn; Tzyy-Wen Chiou; Shinn-Zong Lin
Journal:  Tzu Chi Med J       Date:  2021-02-06

Review 4.  Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review.

Authors:  Shuangqiu Wang; Jiarui Ma; Yanqi Zeng; Guowei Zhou; Yuxuan Wang; Wenjuan Zhou; Xiaohe Sun; Minghua Wu
Journal:  Drug Des Devel Ther       Date:  2021-08-20       Impact factor: 4.162

5.  Molecular mechanism of Epimedium in the treatment of vascular dementia based on network pharmacology and molecular docking.

Authors:  Chenchen Xie; Hao Tang; Gang Liu; Changqing Li
Journal:  Front Aging Neurosci       Date:  2022-08-16       Impact factor: 5.702

6.  Icariin Ameliorates Diabetic Renal Tubulointerstitial Fibrosis by Restoring Autophagy via Regulation of the miR-192-5p/GLP-1R Pathway.

Authors:  Zhirong Jia; Kaiwei Wang; Yameng Zhang; Yalei Duan; Kang Xiao; Shuo Liu; Xuansheng Ding
Journal:  Front Pharmacol       Date:  2021-07-19       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.